Status:
COMPLETED
A Comparative Clinical Investigation of Two Hearing Instrument Digital Signal Processing
Lead Sponsor:
Bernafon AG
Conditions:
Hearing Loss
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to show that the performance of the new digital signal processing system is better than the system used in the currently CE marked devices. Speech in narrowband noise and ...
Detailed Description
This is a controlled, double-blinded, comparative clinical evaluation conducted monocentric at the premised of Bernafon AG in Bern, Switzerland. For this study, Bernafon AG will carry out testing wit...
Eligibility Criteria
Inclusion
- Hearing loss (sensorineural, conductive, mixed-must have doctor approval for mixed and conductive Hearing loss)
- Severity of Hearing loss ranging from mild to profound
- German speaking
- Current Hearing aid users
- Ability and willingness to sign the consent form
Exclusion
- Contraindications for amplification
- New Hearing aid users
- Inability to follow the procedures
- Inability to attend Weekly study Appointments
- Strongly reduced dexterity
- Central Hearing disorders
- Bernafon employees
- Family members of Bernafon employees
Key Trial Info
Start Date :
August 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT04374851
Start Date
August 3 2020
End Date
November 30 2020
Last Update
January 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bernafon AG
Bern, Switzerland, 3018